SIRT6 Allosteric Activator Compound Design

The patent applies parameter changes by systematically varying molecular parameters including substituent types (halogen, hydroxyl, nitro, amino, carboxyl, etc.), positions (R1-R13), and nitrogen-containing heterocyclic ring structures to optimize SIRT6 binding affinity and deacetylation activation. This structure-activity relationship optimization resolves the contradiction by creating a series of compounds with progressively improved regulatory reliability

The patent employs composite molecular design by combining multiple functional elements: a core structure with specific substituents (R1-R13), nitrogen-containing heterocyclic rings, and pharmacologically acceptable salts. This composite approach creates a multifunctional molecule that simultaneously achieves SIRT6 binding, allosteric activation, and pharmaceutical stability

The patent segments the molecule into distinct functional regions: a core structure, multiple substituent positions (R1-R13) that can be independently optimized, and nitrogen-containing heterocyclic ring components. This segmentation allows systematic optimization of binding affinity at each region while maintaining overall structural manageability

The patent applies local quality by assigning specific functional roles to different parts of the molecule: certain substituents (R1-R5) optimize SIRT6 binding, while others (R6-R13) modulate pharmacological properties. The nitrogen-containing heterocyclic rings provide specific allosteric activation functionality. This localized functional assignment enhances deacetylation activity without requiring uniform complexity throughout the entire structure